Altered splicing leads to reduced activation of CPEB3 in high-grade gliomas

• Published in: Oncotarget 2016-07, Vol.7 (27), p.41898-41912
• Main Authors: Skubal, Magdalena, Gielen, Gerrit H, Waha, Anke, Gessi, Marco, Kaczmarczyk, Lech, Seifert, Gerald, Freihoff, Dorothee, Freihoff, Johannes, Pietsch, Torsten, Simon, Matthias, Theis, Martin, Steinhäuser, Christian, Waha, Andreas
• Format: Article
• Language: English
• Subjects: Alternative Splicing; Brain Neoplasms - genetics; Brain Neoplasms - metabolism; Brain Neoplasms - pathology; Cell Line, Tumor; Disease Progression; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Glioma - genetics; Glioma - metabolism; Glioma - pathology; Humans; Male; Neoplasm Grading; Phosphorylation; Protein Isoforms - genetics; Protein Isoforms - metabolism; Research Paper; RNA Isoforms - genetics; RNA Isoforms - metabolism; RNA, Messenger - genetics; RNA, Messenger - metabolism; RNA-Binding Proteins - genetics; RNA-Binding Proteins - metabolism
• ISSN: 1949-2553; 1949-2553
• DOI: 10.18632/oncotarget.9735

Cytoplasmic polyadenylation element binding proteins (CPEBs) are auxiliary translational factors that associate with consensus sequences present in 3'UTRs of mRNAs, thereby activating or repressing their translation. Knowing that CPEBs are players in cell cycle regulation and cellular senescence prompted us to investigate their contribution to the molecular pathology of gliomas-most frequent of intracranial tumors found in humans. To this end, we performed methylation analyses in the promoter regions of CPEB1-4 and identified the CPEB1 gene to be hypermethylated in tumor samples. Decreased expression of CPEB1 protein in gliomas correlated with the rising grade of tumor malignancy. Abundant expression of CPEBs2-4 was observed in several glioma specimens. Interestingly, expression of CPEB3 positively correlated with tumor progression and malignancy but negatively correlated with protein phosphorylation in the alternatively spliced region. Our data suggest that loss of CPEB3 activity in high-grade gliomas is caused by expression of alternatively spliced variants lacking the B-region that overlaps with the kinase recognition site. We conclude that deregulation of CPEB proteins may be a frequent phenomenon in gliomas and occurs on the level of transcription involving epigenetic mechanism as well as on the level of mRNA splicing, which generates isoforms with compromised biological properties.